Narcolepsy:Clinical Features, New Pathophysiologic Insights, and Future Perspectives
- 1 March 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 18 (2) , 78-105
- https://doi.org/10.1097/00004691-200103000-00002
Abstract
Narcolepsy is characterized by excessive daytime sleepiness and abnormal manifestations of rapid eye movement sleep such as cataplexy. The authors review the clinical features of narcolepsy, including epidemiology, symptoms, diagnosis, and treatment, in detail. Recent findings show that a loss of hypocretin-producing neurons lies at the root of the signs and symptoms of narcolepsy. The authors review the current state of knowledge on hypocretin anatomy, physiology, and function with special emphasis on the research regarding the hypocretin deficiency in narcolepsy, which may also explain associated features of the disorder, such as obesity. Lastly, they discuss some future perspectives for research into the pathophysiology of sleep/wake disorders, and the potential impact of the established hypocretin deficiency on the diagnosis and treatment of narcolepsy.Keywords
This publication has 238 references indexed in Scilit:
- Inhibition of Food Intake by Central Injection of Anti-orexin Antibody in Fasted RatsBiochemical and Biophysical Research Communications, 2000
- Orexins, Orexigenic Hypothalamic Neuropeptides, Suppress the Pulsatile Secretion of Luteinizing Hormone in Ovariectomized Female RatsBiochemical and Biophysical Research Communications, 1999
- Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic systemJournal of Comparative Neurology, 1999
- Erratum to: Distribution of orexin receptor mRNA in the rat brain (FEBS 21024)FEBS Letters, 1999
- Stimulation of Gastric Acid Secretion by Centrally Administered Orexin-A in Conscious RatsBiochemical and Biophysical Research Communications, 1999
- Independent Feeding and Metabolic Actions of Orexins in MiceBiochemical and Biophysical Research Communications, 1998
- CSF substance P, somatostatin and monoaminergic transmitter metabolites in patients with narcolepsyNeuroscience Letters, 1996
- The multiple sleep latency test: a paradoxical test?Clinical Neurology and Neurosurgery, 1992
- TREATMENT OF NARCOLEPSY WITH L-TYROSINE: DOUBLE-BLIND PLACEBO-CONTROLLED TRIALThe Lancet, 1989
- Epileptoide SchlafzuständeArchiv Fur Psychiatrie Und Nervenkrankheiten, 1878